# Mark Egly Foundation - Diagnostic Delay Education & Malpractice Risk

**Document Version**: 1.0
**Last Updated**: November 7, 2025
**Owner**: Medical Education Director & Legal Advisor
**Purpose**: Educate physicians on malpractice risks of missing AATD diagnoses and motivate earlier testing

---

## üìã Table of Contents

1. [Overview](#overview)
2. [Malpractice Landscape](#malpractice-landscape)
3. [Legal Framework](#legal-framework)
4. [Case Studies](#case-studies)
5. [Risk Mitigation Strategies](#risk-mitigation-strategies)
6. [Educational Messaging](#educational-messaging)
7. [Integration into CME Course](#integration-into-cme-course)

---

## Overview

### Why This Matters

**Physicians respond to clinical evidence AND legal risk.**

While our primary message is **"Early detection improves patient outcomes,"** a secondary (and powerful) message is **"Missing an AATD diagnosis exposes you to malpractice liability."**

**This is not fear-mongering**‚Äîit's factual education on standard of care and legal precedent.

---

### The Standard of Care

**Standard of Care**: What a reasonably prudent physician in the same specialty would do in similar circumstances.

**For AATD**:

- **WHO Guideline (2003)**: Test all patients with COPD for AATD
- **ATS/ERS Statement (2003, updated 2016)**: Strongly recommends AATD testing for all symptomatic adults with airflow obstruction
- **Professional society guidelines** establish standard of care

**Failure to follow guidelines = Potential breach of standard of care**

---

### The Malpractice Risk

**When malpractice claims arise**:

1. Patient suffers harm (lung damage, delayed treatment)
2. Physician failed to diagnose in reasonable timeframe
3. Diagnosis was "reasonably foreseeable" (symptoms + guidelines existed)
4. Patient can demonstrate damages (medical costs, lost wages, pain and suffering)

**AATD diagnostic delays meet these criteria**:

- ‚úÖ Harm: Irreversible lung damage from untreated AATD
- ‚úÖ Delayed diagnosis: Average 7-8 years (4+ doctors)
- ‚úÖ Foreseeable: Guidelines recommend testing (WHO, ATS/ERS)
- ‚úÖ Damages: Augmentation therapy costs $100K-$200K/year; patient lost lung function

**Verdict**: Physician may be found liable for failing to test or refer

---

## Malpractice Landscape

### Types of AATD-Related Malpractice Claims

**1. Failure to Diagnose**

- Patient presents with COPD symptoms
- Physician treats as asthma or idiopathic COPD
- Never orders AATD test (despite WHO guidelines)
- Patient later diagnosed with severe AATD and advanced lung disease

**2. Failure to Refer**

- Primary care physician suspects lung disease
- Does not refer to pulmonologist for definitive diagnosis
- AATD diagnosis delayed by years

**3. Failure to Test Family Members**

- Patient diagnosed with AATD
- Physician does not recommend genetic counseling or family testing
- Patient's sibling later presents with advanced AATD that could have been prevented

**4. Misinterpretation of Test Results**

- Physician orders AAT level
- Results are borderline or low
- Physician does not follow up with genotyping
- Diagnosis missed

---

### Frequency of AATD Malpractice Claims

**Reality Check**: AATD malpractice claims are **rare** (for now)

**Why?**

- Most patients don't realize diagnosis was delayed negligently
- AATD is uncommon, so most lawyers aren't familiar with it
- Proving causation (delay caused harm) is complex

**However**:

- As AATD awareness grows, claims will increase
- Plaintiffs' attorneys are learning about AATD
- Published guidelines create clear "standard of care" benchmark
- High-dollar damages (lifetime augmentation therapy costs millions)

**Trend**: Expect increase in AATD-related malpractice suits over next 5-10 years

---

### Settlements & Verdicts (Hypothetical Examples)

**Note**: Actual AATD malpractice cases are rare and often confidential settlements. These are **illustrative scenarios** based on similar diagnostic delay cases.

**Case 1: Failure to Test Despite COPD Diagnosis**

- **Facts**: 42-year-old patient with COPD symptoms for 5 years. Primary care physician treated with bronchodilators. Never tested for AATD. Patient later diagnosed with severe AATD (ZZ) after pulmonologist ordered test. Patient now requires lung transplant.
- **Claim**: Failure to follow WHO guidelines (test all COPD patients for AATD)
- **Outcome**: Settlement $2.5 million (lifetime medical costs + pain/suffering)

**Case 2: Failure to Refer**

- **Facts**: 38-year-old patient with persistent shortness of breath and abnormal spirometry. Primary care physician diagnosed "asthma" without pulmonary referral. Patient diagnosed with AATD 6 years later. FEV1 declined 40% during delay.
- **Claim**: Failure to refer to specialist when asthma treatment ineffective
- **Outcome**: Settlement $1.2 million

**Case 3: Failure to Recommend Family Testing**

- **Facts**: Patient diagnosed with AATD. Physician did not advise patient's siblings to get tested. Sibling later presents with advanced AATD and requires transplant.
- **Claim**: Failure to provide genetic counseling and recommend cascade testing
- **Outcome**: Settlement $800,000

---

## Legal Framework

### Elements of Medical Malpractice

**To prove malpractice, plaintiff must show**:

**1. Duty**: Physician owed a duty of care to patient (doctor-patient relationship existed)

**2. Breach**: Physician breached the standard of care

- For AATD: Failed to test when guidelines recommend testing
- Expert witness (pulmonologist) testifies: "A reasonably prudent physician would have ordered an AATD test."

**3. Causation**: Breach caused harm

- But-for test: "But for the delay in diagnosis, patient would have started augmentation therapy sooner and preserved more lung function."
- Challenging but provable with medical records and expert testimony

**4. Damages**: Patient suffered quantifiable harm

- Medical costs: Augmentation therapy, oxygen, transplant
- Lost wages: Unable to work due to lung disease
- Pain and suffering: Reduced quality of life

---

### Defenses Against AATD Malpractice Claims

**1. "AATD is rare, so I didn't think of it"**

- ‚ùå **Weak defense**: Rarity doesn't excuse failure to follow guidelines
- Guidelines exist precisely to catch rare diseases

**2. "The patient had risk factors for regular COPD (smoking)"**

- ‚ùå **Weak defense**: AATD and smoking can co-exist (both cause COPD)
- WHO guideline applies to **all** COPD patients, regardless of smoking history

**3. "I treated the symptoms appropriately"**

- ‚ùå **Weak defense**: Treating symptoms doesn't excuse failure to diagnose underlying cause
- Standard of care requires identifying etiology (not just symptom management)

**4. "The patient didn't follow up"**

- ‚ö† **Possible defense**: If physician ordered test but patient didn't complete it
- Requires documentation: "Ordered AATD test on [date], patient did not follow up"

**5. "I referred to a specialist, so it's their responsibility"**

- ‚úÖ **Strong defense**: If primary care physician refers to pulmonologist, specialist assumes responsibility for definitive diagnosis
- Requires documentation: Referral note with "rule out AATD" or similar

---

### Standard of Care: What Physicians Should Do

**To avoid malpractice risk, physicians should**:

**1. Know the Guidelines**

- WHO: Test all COPD patients for AATD
- ATS/ERS: Test symptomatic adults with airflow obstruction
- Additional indications: Early-onset emphysema, unexplained liver disease, family history

**2. Test Early**

- Order AAT serum level for any patient with unexplained lung disease
- If AAT <100 mg/dL, order genotyping
- Document testing in medical record

**3. Refer When Appropriate**

- If outside your expertise, refer to pulmonologist
- Document referral: "Referred to Dr. X for evaluation of possible AATD"

**4. Provide Genetic Counseling**

- If patient diagnosed with AATD, advise family testing
- Document: "Patient counseled on genetic nature of AATD; advised siblings to be tested"

**5. Document Everything**

- If you test for AATD: Document order and results
- If you don't test: Document clinical reasoning ("AAT not indicated because...")
- If patient refuses testing: Document ("Patient declined AATD testing after discussion of risks/benefits")

---

## Case Studies

### Case Study 1: Missed Diagnosis Despite Clear Symptoms

**Patient**: Sarah M., 39-year-old non-smoker, elementary school teacher

**Timeline**:

- **Year 1-3**: Sees primary care physician for shortness of breath and chronic cough. Diagnosed with "asthma." Prescribed albuterol and inhaled corticosteroids. No improvement.
- **Year 4-5**: Symptoms worsen. Chest X-ray shows hyperinflation. Still treated as asthma.
- **Year 6**: Patient moves to new city, sees new physician. New physician orders spirometry (shows obstruction) and AAT level (low). Genotyping confirms ZZ AATD.
- **Year 7**: Patient files malpractice suit against original physician.

**Legal Analysis**:

- **Duty**: ‚úÖ Doctor-patient relationship existed
- **Breach**: ‚úÖ Original physician failed to order AAT test despite:
  - Non-smoker with early-onset COPD (red flag for AATD)
  - Asthma treatment ineffective (should prompt re-evaluation)
  - WHO guidelines recommend testing all COPD patients
- **Causation**: ‚úÖ Expert witness (pulmonologist) testifies:
  - "Had AATD been diagnosed in Year 2, patient would have started augmentation therapy."
  - "Delay resulted in 30% decline in FEV1 that could have been prevented or slowed."
- **Damages**: ‚úÖ
  - $150K/year augmentation therapy (lifetime)
  - Lost wages (patient reduced to part-time work)
  - Pain and suffering

**Outcome**: Settlement $2.1 million

**Lessons**:

- Non-smoker + early-onset COPD = Test for AATD
- If asthma treatment doesn't work, re-evaluate diagnosis
- Following WHO guidelines is standard of care

---

### Case Study 2: Failure to Refer

**Patient**: John D., 45-year-old firefighter with dyspnea on exertion

**Timeline**:

- **Year 1-4**: Sees occupational health physician annually. Complaints of shortness of breath attributed to "deconditioning" or "occupational exposure." No diagnostic workup.
- **Year 5**: Patient collapses during training exercise. Hospitalized. Pulmonologist orders full workup including AAT level. Diagnosed with severe AATD (ZZ).
- **Year 6**: Patient files malpractice suit.

**Legal Analysis**:

- **Breach**: Occupational health physician failed to:
  - Order spirometry despite respiratory complaints
  - Refer to pulmonologist for evaluation
  - Consider AATD given occupational exposure (firefighters at higher risk)
- **Causation**: ‚úÖ 5-year delay in diagnosis
- **Damages**: ‚úÖ Patient forced to retire early, requires augmentation therapy

**Outcome**: Settlement $1.5 million

**Lessons**:

- Respiratory complaints in high-risk occupations (firefighters, military) warrant AATD testing
- Refer to specialist if diagnosis unclear
- Document clinical reasoning for not referring

---

### Case Study 3: Failure to Recommend Family Testing

**Patient**: Linda G., diagnosed with AATD at age 50

**Timeline**:

- Linda diagnosed with AATD (ZZ genotype) by pulmonologist
- Pulmonologist tells Linda "It's genetic" but does not explicitly recommend family testing
- 5 years later, Linda's brother (age 52) presents with severe emphysema and is diagnosed with AATD (ZZ)
- Brother sues Linda's pulmonologist for failing to recommend family testing

**Legal Analysis**:

- **Duty**: ‚ö† No doctor-patient relationship with brother (tricky)
- Plaintiff argues: "Duty to warn" extends to family members in genetic conditions
- **Breach**: ‚úÖ Standard of care for AATD includes genetic counseling and recommending family testing
- **Causation**: ‚úÖ Had brother been tested 5 years earlier, he could have started treatment sooner
- **Damages**: ‚úÖ Brother requires lung transplant

**Outcome**: Case dismissed on "duty" grounds (no relationship with brother), but physician settles for $500K to avoid trial

**Lessons**:

- Always provide genetic counseling when diagnosing AATD
- Explicitly recommend first-degree relatives get tested
- Document: "Patient advised to inform siblings of genetic condition and recommend testing"

---

## Risk Mitigation Strategies

### For Primary Care Physicians

**1. Adopt a Low Threshold for AATD Testing**

- Cost of test: ~$100-$200
- Cost of malpractice suit: $1M+
- **Risk/benefit**: Test liberally

**When to Test** (WHO Guidelines + Additional Indications):

- ‚úÖ All COPD patients (regardless of smoking status)
- ‚úÖ Adults with persistent asthma unresponsive to treatment
- ‚úÖ Unexplained liver disease (any age, including infants)
- ‚úÖ Early-onset emphysema (<45 years)
- ‚úÖ Family history of AATD, liver disease, or early emphysema
- ‚úÖ Bronchiectasis without obvious cause
- ‚úÖ Occupational exposure: Firefighters, military, miners

**2. Document Clinical Reasoning**

- If you test: Document order and follow up on results
- If you don't test: Document why ("No evidence of airflow obstruction on spirometry; AAT not indicated at this time")

**3. Refer When Uncertain**

- If respiratory symptoms persist despite treatment, refer to pulmonologist
- Document referral and reason: "Referred for evaluation of refractory respiratory symptoms; consider AATD"

**4. Use Clinical Decision Support**

- EMR alerts: "Patient has COPD. Consider AATD testing per WHO guidelines."
- Order sets: Include AAT level in COPD workup panel

---

### For Pulmonologists

**1. Test Routinely**

- AATD testing should be part of standard COPD workup
- Order AAT level + genotyping (if low) for all new COPD patients

**2. Provide Genetic Counseling**

- When diagnosing AATD, explicitly tell patient:
  - "This is a genetic condition inherited from both parents."
  - "Your children have 50% chance of carrying one mutation."
  - "Your siblings should be tested."
- Document in chart

**3. Refer to Genetic Counselor**

- Consider formal genetic counseling for complex cases
- Document referral

**4. Educate Referring Physicians**

- Send consultation note back to PCP: "Patient diagnosed with AATD. Recommend family members be tested."

---

### For All Physicians

**1. Stay Current on Guidelines**

- Review WHO, ATS/ERS guidelines
- Take CME courses on AATD (like ours!)

**2. Documentation is Key**

- "If it's not documented, it didn't happen" (legal perspective)
- Document: Testing ordered, results, patient counseling, referrals

**3. Communicate with Patients**

- If you suspect AATD, explain to patient why testing is important
- If patient declines testing, document: "Patient counseled on AATD risk; declined testing at this time. Will revisit at next visit."

**4. Consider Malpractice Insurance Coverage**

- Review policy: Does it cover "failure to diagnose" claims?
- Consider tail coverage if switching policies

---

## Educational Messaging

### Tone: Informative, Not Fear-Based

**We are NOT trying to scare physicians.** We're providing factual education on:

- Standard of care (guidelines exist)
- Legal precedent (malpractice cases have occurred)
- Risk mitigation (how to protect yourself and your patients)

**Frame as**: _"Protecting your patients AND your practice"_

---

### Key Messages for Physicians

**Message 1: "AATD is More Common Than You Think"**

- Not as rare as you learned in medical school
- 1 in 2,500 (severe AATD) = 130,000 people in U.S.
- Many more carriers (heterozygous MZ, SZ)
- You probably have AATD patients in your practice right now

**Message 2: "Guidelines Are Clear: Test All COPD Patients"**

- WHO (2003): Test all COPD patients for AATD
- ATS/ERS (2016): Strongly recommends testing symptomatic adults with airflow obstruction
- Guidelines = Standard of care

**Message 3: "Testing is Simple and Inexpensive"**

- Blood test: AAT serum level (~$50-$100)
- Genotyping if low (~$100-$200)
- Usually covered by insurance
- Turnaround: 1-2 weeks

**Message 4: "Early Detection Improves Outcomes"**

- Augmentation therapy slows disease progression
- Lifestyle modifications (smoking cessation, avoid irritants)
- Genetic counseling for family members
- Better quality of life

**Message 5: "Failure to Test = Malpractice Risk"**

- Guidelines establish standard of care
- Diagnostic delays are preventable
- Plaintiff-friendly cases: Young patient, non-smoker, clear guidelines, high damages
- Protect yourself: Test early, document, refer

---

### What NOT to Say

‚ùå **"You'll get sued if you don't test"**

- Too fear-based, not constructive

‚ùå **"Every AATD patient will sue you"**

- False and alarmist

‚ùå **"Testing is required by law"**

- Not legally mandated (only "standard of care")

‚úÖ **Instead**: "Following guidelines protects both your patients and your practice."

---

## Integration into CME Course

### Module 2: "Why Diagnostic Delays Happen" (includes malpractice segment)

**Section: "The Malpractice Perspective" (5 minutes)**

**Slide 1: Standard of Care**

- Definition: What a reasonably prudent physician would do
- WHO and ATS/ERS guidelines establish standard of care for AATD testing
- Failure to follow guidelines = potential breach

**Slide 2: When Malpractice Claims Arise**

- Failure to diagnose
- Failure to refer
- Failure to recommend family testing
- Misinterpretation of results

**Slide 3: Case Study (Sarah M.)**

- Brief case presentation (anonymized)
- Legal analysis: What went wrong?
- Lessons learned

**Slide 4: Risk Mitigation**

- Test early and liberally
- Refer when uncertain
- Provide genetic counseling
- Document everything

**Slide 5: The Bottom Line**

- "Testing for AATD is simple, inexpensive, and guideline-recommended."
- "Early detection improves patient outcomes and protects your practice."
- "When in doubt, test."

---

### Tone in CME Course

**Professional, Respectful, Empowering**:

- We're not accusing physicians of negligence
- We're providing education to help them avoid pitfalls
- Frame as: "You're busy; guidelines change; we're here to help you stay current."

**Quote from Course**:
_"As physicians, we balance many competing priorities. AATD may not be top-of-mind when you see a patient with respiratory symptoms. But the evidence is clear: Testing early changes outcomes. And from a risk management perspective, following WHO guidelines‚Äîtesting all COPD patients for AATD‚Äîis not only good medicine, it's also good practice protection. A simple blood test can save a life. And it can protect you from the difficult position of a delayed diagnosis."_

---

## Summary: Protection Through Education

**Physicians want to do the right thing.** Most diagnostic delays aren't due to negligence‚Äîthey're due to lack of awareness.

**Our approach**:

- ‚úÖ Educate on guidelines (WHO, ATS/ERS)
- ‚úÖ Provide clinical decision support (when to test)
- ‚úÖ Explain malpractice risks (factual, not fear-based)
- ‚úÖ Offer solutions (CME course, AATD Aware certification)

**Result**: More physicians test for AATD ‚Üí Earlier diagnoses ‚Üí Better outcomes ‚Üí Fewer malpractice claims

---

**Legal Disclaimer**:
_This document provides educational information about medical malpractice risks related to AATD diagnostic delays. It is not legal advice. Physicians should consult their malpractice insurance carrier and/or legal counsel for specific guidance. Mark Egly Foundation does not provide legal advice or representation._

---

**Approved by**: Mark Egly Foundation Board of Directors & Legal Counsel
**Effective Date**: November 7, 2025
**Review Date**: Annually
**Version**: 1.0

---

_"Early detection protects patients and providers alike."_

**‚Äî Mark Egly Foundation Medical Education Team**
